Le Lézard
Classified in: Health
Subject: PER

Biovica Strengthens Management Team

STOCKHOLM, Dec. 6, 2019 /PRNewswire/ -- Biovica, active in cancer diagnostics, today announced that Henrik Winther was appointed SVP Business Development and will be part of the management team. He most recently comes from the role of SVP Precision Diagnostics at Immunovia.

"Henrik possesses a rare combination of scientific expertise and commercial experience. With his many years of diagnostics background, he brings with him tremendous insight and an extensive network of contacts. Henrik is an important piece of the puzzle in Biovica's continued market expansion," said Anders Rylander, CEO of Biovica.

Winther has previously worked as Global VP of Business Development at the Danish diagnostics company Dako and later as General Manager of the Companion Diagnostic (CDx) Division at Agilent Technologies based in California. Earlier in his career, Winther headed the R&D diagnostic reagents development at Dako. Prior to that he was associate professor in anatomy, physiology and cell biology at the University of Copenhagen. He will start at Biovica on November 18.

"For a decade, Companion Diagnostics i.e. patient stratification for the right individualized treatment has been the focus of the industry. Now, the next very important topic to secure safe and effective treatments within personalized cancer medicine is the monitoring of patient response to therapy," said Winther.

"Biovica is in a strong position with its DiviTum test which provides a unique tool to oncologists that allows for a fast, robust and reliable assessment of patients' response to a given treatment. DiviTum really has a great potential as it is already CE marked, has interesting applications, support from key opinion leaders globally and several excellent clinical study results. The pieces are in place to take Biovica to the next level," he said.

When:     6 December 2019 at 10.00 CET
Where:   https://tv.streamfabriken.com/biovica-international-q2-2019 or
SE: +46850558369 / DK: +4578150107 / UK: +443333009261 / US: +18335268384
Broadcast language: in English


For more information
Anders Rylander, CEO Biovica
phone: +46 (0)18 444 48 35
email: anders.rylander@biovica.com

This information was brought to you by Cision http://news.cision.com


The following files are available for download:




Henrik Winther bw-s

SOURCE Biovica International AB

These press releases may also interest you

at 08:07
"Scientists, physicians and public health experts continue to learn about COVID-19 and how it is spread. We must use the limited tools we have today to slow the spread of the COVID-19 virus and minimize the damage it causes to individuals, our...

at 08:05
Pfizer Inc. today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead's investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of...

at 08:05
Bruker Corporation today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on September 18, 2020 to stockholders of...

at 08:05
Senseonics Holdings, Inc. , a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced Highmark Inc. will begin...

at 08:05
Aimmune Therapeutics, Inc. , a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that its President and Chief Executive Officer, Jayson Dallas, M.D., will present at...

at 08:00
Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19). DateAugust 7, 2020 Time12:00 PM (EDT) LocationWest Block, Room 225Parliament HillWellington Street, Ottawa, Ontario The media...

News published on 6 december 2019 at 02:08 and distributed by: